rs201033859
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000744.7(CHRNA4):c.345C>T(p.Ser115=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000059 in 1,611,404 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S115S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000744.7 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHRNA4 | NM_000744.7 | c.345C>T | p.Ser115= | synonymous_variant | 4/6 | ENST00000370263.9 | |
CHRNA4 | NM_001256573.2 | c.-202C>T | 5_prime_UTR_variant | 4/6 | |||
CHRNA4 | NR_046317.2 | n.554C>T | non_coding_transcript_exon_variant | 4/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHRNA4 | ENST00000370263.9 | c.345C>T | p.Ser115= | synonymous_variant | 4/6 | 1 | NM_000744.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000464 AC: 7AN: 150700Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249814Hom.: 0 AF XY: 0.0000885 AC XY: 12AN XY: 135602
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1460586Hom.: 1 Cov.: 32 AF XY: 0.0000688 AC XY: 50AN XY: 726602
GnomAD4 genome AF: 0.0000464 AC: 7AN: 150818Hom.: 0 Cov.: 30 AF XY: 0.0000272 AC XY: 2AN XY: 73638
ClinVar
Submissions by phenotype
Autosomal dominant nocturnal frontal lobe epilepsy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 10, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at